TOVX - Theriva Biologics, Inc.

QQQ $ 439.97 $ 4.77 (1.1 %)

DIA $ 388.40 $ 1.68 (0.43 %)

SPY $ 516.34 $ 5.28 (1.03 %)

TLT $ 90.16 $ 0.35 (0.39 %)

GLD $ 215.21 $ 2.24 (1.05 %)

Previous Close

$ 0.4

Open

$ 0.40

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 0.40 - $ 0.42

52 Week Range

$ 0.20 - $ 1.20

Volume

37,765

Average Volume

Market Cap

6.44M

Beta (5Y Monthly)

$ 1.51

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-25-2024	12-31-2023	10-K
2	11-13-2023	09-30-2023	10-Q
3	08-08-2023	06-30-2023	10-Q
4	05-11-2023	03-31-2023	10-Q
5	03-30-2023	12-31-2022	10-K
6	11-10-2022	09-30-2022	10-Q
7	08-11-2022	06-30-2022	10-Q
8	05-16-2022	03-31-2022	10-Q
9	03-16-2022	12-31-2021	10-K
10	11-03-2021	09-30-2021	10-Q
11	08-05-2021	06-30-2021	10-Q
12	05-05-2021	03-31-2021	10-Q
13	03-04-2021	12-31-2020	10-K
14	11-10-2020	09-30-2020	10-Q
15	08-06-2020	06-30-2020	10-Q
16	05-05-2020	03-31-2020	10-Q
17	02-20-2020	12-31-2019	10-K
18	11-04-2019	09-30-2019	10-Q
19	08-08-2019	06-30-2019	10-Q
20	05-08-2019	03-31-2019	10-Q
21	02-27-2019	12-31-2018	10-K
22	11-08-2018	09-30-2018	10-Q
23	08-08-2018	06-30-2018	10-Q
24	05-08-2018	03-31-2018	10-Q
25	02-22-2018	12-31-2017	10-K
26	11-01-2017	09-30-2017	10-Q
27	08-03-2017	06-30-2017	10-Q
28	05-04-2017	03-31-2017	10-Q
29	03-02-2017	12-31-2016	10-K
30	11-01-2016	09-30-2016	10-Q
31	08-03-2016	06-30-2016	10-Q
32	05-05-2016	03-31-2016	10-Q
33	03-10-2016	12-31-2015	10-K
34	11-05-2015	09-30-2015	10-Q
35	08-10-2015	06-30-2015	10-Q
36	05-11-2015	03-31-2015	10-Q
37	03-16-2015	12-31-2014	10-K
38	11-14-2014	09-30-2014	10-Q
39	08-14-2014	06-30-2014	10-Q
40	05-15-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Theriva Biologics Files Mixed-Securities S...
05/02/2024 21:21:18

Theriva Biologics To Discuss The Trial Des...
04/25/2024 12:34:38

Theriva™ Biologics (NYSE:TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and relat...

$theriva-biologics-disclosed-positive-topline-data-from-investigator-sponsored-phase-1-trial-of-intravitreal-vcn-01-in-pediatric-patients-with-refractory-retinoblastoma$

Theriva Biologics Disclosed Positive Topli...
04/23/2024 12:40:08

Why Hibbett Shares Are Trading Higher By 1...
04/23/2024 12:00:50

Theriva Biologics To Present Preclinical D...
04/22/2024 20:37:21

– Lead product candidate, VCN-01 in combination with liposomal irinotecan demonstrated enhanced anti-tumor effects in a human p...

Theriva Biologics FY EPS $(1.14) Beats $(1...
03/25/2024 11:32:39

Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(1.14) per share which beat the analyst consensus estimate of $(1.2...

Earnings Scheduled For March 25, 2024
03/25/2024 09:33:46

Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on re...

Preview: Theriva Biologics's Earnings
03/22/2024 14:01:40

Theriva Biologics Granted EU Patent #32921...
03/20/2024 20:01:09

https://data.epo.org/publication-server/pdf-document?pn=3292142&ki=B1&cc=EP

Theriva Biologics Announces Positive Recom...
02/07/2024 13:02:56

Theriva™ Biologics (NYSE:TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and relat...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
12/25/2023 17:30:49

Theriva Biologics Q3 EPS $(0.19) Beats $(0...
11/13/2023 13:05:17

Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.3...

Earnings Scheduled For November 13, 2023
11/13/2023 11:40:53

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr...

Earnings Outlook For Theriva Biologics
11/10/2023 18:01:46

Theriva Biologics And Sant Joan de Déu-Bar...
11/02/2023 12:06:33

Theriva Biologics Announced New Clinical D...
10/23/2023 11:12:18

These data were presented at the European Society for Medical Oncology (ESMO) Congress, held both virtually and in Madrid, Spai...

Theriva Biologics Announces Presentation A...
10/16/2023 12:31:10

-Results from investigator-sponsored study in collaboration with the Institut Catala d'Oncologia (ICO) show enhanced patien...

Theriva Biologics Q2 EPS $(0.34) Down From...
08/08/2023 12:07:44

Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.34) per share. This is a 9.68 percent decrease over losses of $(...

Earnings Scheduled For August 8, 2023
08/08/2023 08:48:24

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly earnings at $0.21 per share o...

Theriva Biologics Progresses VIRAGE Phase ...
08/02/2023 11:12:14